Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study

Background Patient-reported outcomes are increasingly used in the management of patients with multiple sclerosis to understand the patient's perspective of disease and treatment. These measures provide insights into important factors including treatment satisfaction, physical and psychological...

Full description

Bibliographic Details

Published in:	Multiple sclerosis journal - experimental, translational and clinical Vol. 8; no. 4; p. 20552173221135888
Main Authors:	Wray, Sibyl, Jacques, Francois, Miller, Tamara A, Nicholas, Jacqueline A, Arroyo, Rafael, Travis, Lori, Khatri, Bhupendra, Chirieac, Magdalena, Gandhi, Roopali, Roesch, Nora, Rodrigues, Amelie, Melas-Melt, Lydie, Rawlings, Andreea M, Hunter, Samuel F
Format:	Journal Article
Language:	English
Published:	London, England SAGE Publications 01.10.2022 Sage Publications Ltd
Subjects:	Monoclonal antibodies Multiple sclerosis Original Patients disease-modifying therapies Alemtuzumab quality of life multiple sclerosis
ISSN:	2055-2173, 2055-2173
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!